Legal Opinion
Braintree Laboratories, Inc. v. Schwarz Pharma, Inc.
District Court, D. Delaware
Decided July 31, 2008No. Civ. 03-477-SLRPublishedCited by 5 opinions
1Opinion of the Court
OPINION
SUE L. ROBINSON, District Judge.
I. INTRODUCTION
This action arises out of the filing of an Abbreviated New Drug Application (“ANDA”) 1 by Schwarz Pharma, Inc. (“SPI”) to market a generic version of the constipation drug MIRALAX® proprietary to Braintree Laboratories, Inc. (“Braintree”). MIRALAX® has a single ingredient, polyethylene glycol 3350 (“PEG”); the administration of PEG to treat constipation is protected by claim 33 of U.S. Patent No. 5,710,183 (“the '183 patent”). Braintree brought a patent infringement suit pursuant to 35 U.S.C. § 271(e)(2)(A) 2 on May 16, 2003. (D.I.l)…
2Cases cited15 opinions
- Eastern Railroad Presidents Conference v. Noerr Motor Freight, Inc.Supreme Court of the United States · 1961
- United Mine Workers v. PenningtonSupreme Court of the United States · 1965
- California Motor Transport Co. v. Trucking UnlimitedSupreme Court of the United States · 1972
- Professional Real Estate Investors, Inc. v. Columbia Pictures Industries, Inc.Supreme Court of the United States · 1993
- MCI Communications Corporation and MCI Telecommunications Corporation v. American Telephone and Telegraph CompanyCourt of Appeals for the Seventh Circuit · 1983
10 more not listed; retrieve them via the Exa API.
3Cited by5 opinions
- Eastern Savings Bank, Fsb v. PapageorgeDistrict Court, District of Columbia · 2014
- Rochester Drug Co-Operative v. Braintree LaboratoriesDistrict Court, D. Delaware · 2010
- Rochester Drug Co-Operative, Inc. v. Braintree LaboratoriesDistrict Court, D. Delaware · 2011
- Florcsk v. Unstoppable Domains Inc.District Court, D. Delaware · 2024
- UnderCover, Inc. v. Rough Country, LLCDistrict Court, W.D. Tennessee · 2024